Literature DB >> 12163447

Optimizing hematopoietic stem cell engraftment: a novel role for thrombopoietin.

Catherine M Verfaillie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12163447      PMCID： PMC151097          DOI： 10.1172/JCI16376

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  16 in total

1.  Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice.

Authors:  H Glimm; W Eisterer; K Lee; J Cashman; T L Holyoake; F Nicolini; L D Shultz; C von Kalle; C J Eaves
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.

Authors:  O J Borge; V Ramsfjell; L Cui; S E Jacobsen
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

3.  Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.

Authors:  H J McKenna; K L Stocking; R E Miller; K Brasel; T De Smedt; E Maraskovsky; C R Maliszewski; D H Lynch; J Smith; B Pulendran; E R Roux; M Teepe; S D Lyman; J J Peschon
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

Review 4.  Thrombopoietin and the c-Mpl receptor: insights from gene targeting.

Authors:  W S Alexander
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

5.  c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.

Authors:  M Ballmaier; M Germeshausen; H Schulze; K Cherkaoui; S Lang; A Gaudig; S Krukemeier; M Eilers; G Strauss; K Welte
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

6.  Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis.

Authors:  T I Pestina; J L Cleveland; C Yang; G P Zambetti; C W Jackson
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

7.  Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor.

Authors:  K M Zsebo; D A Williams; E N Geissler; V C Broudy; F H Martin; H L Atkins; R Y Hsu; N C Birkett; K H Okino; D C Murdock
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

Review 8.  The murine W/c-kit and Steel loci and the control of hematopoiesis.

Authors:  A Bernstein; L Forrester; A D Reith; P Dubreuil; R Rottapel
Journal:  Semin Hematol       Date:  1991-04       Impact factor: 3.851

9.  Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor.

Authors:  Russell L Basser; Elizabeth O'Flaherty; Michael Green; Maria Edmonds; Janet Nichol; Dora M Menchaca; Brian Cohen; C Glenn Begley
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

10.  Thrombopoietin expands hematopoietic stem cells after transplantation.

Authors:  Norma Fox; Greg Priestley; Thalia Papayannopoulou; Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808
View more
  4 in total

1.  Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.

Authors:  Michael M B Green; Nelson Chao; Saurabh Chhabra; Kelly Corbet; Cristina Gasparetto; Ari Horwitz; Zhiguo Li; Jagadish Kummetha Venkata; Gwynn Long; Alice Mims; David Rizzieri; Stefanie Sarantopoulos; Robert Stuart; Anthony D Sung; Keith M Sullivan; Luciano Costa; Mitchell Horwitz; Yubin Kang
Journal:  J Hematol Oncol       Date:  2016-08-17       Impact factor: 17.388

2.  Selective enhancement of donor hematopoietic cell engraftment by the CXCR4 antagonist AMD3100 in a mouse transplantation model.

Authors:  Yubin Kang; Benny J Chen; Divino Deoliveira; Jeffrey Mito; Nelson J Chao
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

Review 3.  Magnetically Targeted Stem Cell Delivery for Regenerative Medicine.

Authors:  Jhon Cores; Thomas G Caranasos; Ke Cheng
Journal:  J Funct Biomater       Date:  2015-06-30

4.  The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells.

Authors:  John M Ninos; Leigh C Jefferies; Christopher R Cogle; William G Kerr
Journal:  J Transl Med       Date:  2006-02-16       Impact factor: 5.531
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.